3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Pelvic Neoplasms
1
Malnutrition
1
Emergence Delirium
1
Abdominal Neoplasms
1
Interventions
Injections
41
Carboplatin
34
Cisplatin
24
Capecitabine
24
Paclitaxel
23
Docetaxel
23
pembrolizumab
21
Oxaliplatin
21
Gemcitabine
20
Pemetrexed
19
Bevacizumab
18
Fluorouracil
13
Irinotecan
12
Cyclophosphamide
12
osimertinib
9
Nivolumab
8
Dexamethasone
8
tislelizumab
7
Topotecan
7
Leucovorin
7
Doxorubicin
7
130-nm albumin-bound paclitaxel
7
venetoclax
6
toripalimab
6
regorafenib
6
lenvatinib
6
fludarabine
6
Rituximab
6
Cetuximab
6
daratumumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
INDUSTRY
×
serotonin adipinate
×
Clear all
NCT07622888
2026-06-03
GIDNUT
Arma Ltd.
Not yet recruiting
120 enrolled